GenoFocus Inc Cash Flow-to-Debt Ratio
GenoFocus Inc cash flow-to-debt ratio. GenoFocus Inc (187420) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of ₩-821.53 Million could theoretically repay 0% of its total liabilities (₩82.66 Billion) in one year. Check 187420 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of GenoFocus Inc (2014–2025)
Cash flow-to-debt ratio of GenoFocus Inc from 2014 to 2025. Historical debt coverage capacity for GenoFocus Inc across 12 annual periods. Check 187420 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
GenoFocus Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
GenoFocus Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for GenoFocus Inc. For the full cash flow conversion analysis, see cash efficiency ratio of GenoFocus Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | ₩3.50 Billion | ₩81.08 Billion | ▲ +84.4% |
| 2024 | 0.02x | ₩2.87 Billion | ₩122.49 Billion | ▲ +134.8% |
| 2023 | -0.07x | ₩-4.82 Billion | ₩71.50 Billion | ▼ -57.3% |
| 2022 | -0.04x | ₩-4.71 Billion | ₩110.02 Billion | ▼ -49.1% |
| 2021 | -0.03x | ₩-2.39 Billion | ₩83.24 Billion | ▲ +14.0% |
| 2020 | -0.03x | ₩-2.45 Billion | ₩73.46 Billion | ▼ -659.0% |
| 2019 | 0.00x | ₩-167.50 Million | ₩38.08 Billion | ▼ -102.8% |
| 2018 | 0.15x | ₩1.56 Billion | ₩10.12 Billion | ▼ -32.8% |
| 2017 | 0.23x | ₩1.36 Billion | ₩5.93 Billion | ▼ -68.4% |
| 2016 | 0.73x | ₩516.09 Million | ₩709.87 Million | ▼ -81.2% |
| 2015 | 3.88x | ₩2.85 Billion | ₩736.18 Million | ▲ +9952.7% |
| 2014 | -0.04x | ₩-286.45 Million | ₩7.28 Billion | — |